Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,027 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.
Valabrega G, Capellero S, Cavalloni G, Zaccarello G, Petrelli A, Migliardi G, Milani A, Peraldo-Neia C, Gammaitoni L, Sapino A, Pecchioni C, Moggio A, Giordano S, Aglietta M, Montemurro F. Valabrega G, et al. Among authors: giordano s. Breast Cancer Res Treat. 2011 Nov;130(1):29-40. doi: 10.1007/s10549-010-1281-5. Epub 2010 Dec 9. Breast Cancer Res Treat. 2011. PMID: 21153051
ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells.
Valabrega G, Fagioli F, Corso S, Madon E, Brach del Prever A, Biasin E, Linari A, Aglietta M, Giordano S. Valabrega G, et al. Among authors: giordano s. Br J Cancer. 2003 Feb 10;88(3):396-400. doi: 10.1038/sj.bjc.6600735. Br J Cancer. 2003. PMID: 12569382 Free PMC article.
TGFalpha expression impairs Trastuzumab-induced HER2 downregulation.
Valabrega G, Montemurro F, Sarotto I, Petrelli A, Rubini P, Tacchetti C, Aglietta M, Comoglio PM, Giordano S. Valabrega G, et al. Among authors: giordano s. Oncogene. 2005 Apr 21;24(18):3002-10. doi: 10.1038/sj.onc.1208478. Oncogene. 2005. PMID: 15735715
MET overexpression turns human primary osteoblasts into osteosarcomas.
Patanè S, Avnet S, Coltella N, Costa B, Sponza S, Olivero M, Vigna E, Naldini L, Baldini N, Ferracini R, Corso S, Giordano S, Comoglio PM, Di Renzo MF. Patanè S, et al. Among authors: giordano s. Cancer Res. 2006 May 1;66(9):4750-7. doi: 10.1158/0008-5472.CAN-05-4422. Cancer Res. 2006. PMID: 16651428 Free article.
Molecular cancer therapy: can our expectation be MET?
Migliore C, Giordano S. Migliore C, et al. Among authors: giordano s. Eur J Cancer. 2008 Mar;44(5):641-51. doi: 10.1016/j.ejca.2008.01.022. Epub 2008 Mar 4. Eur J Cancer. 2008. PMID: 18295476 Review.
MicroRNAs impair MET-mediated invasive growth.
Migliore C, Petrelli A, Ghiso E, Corso S, Capparuccia L, Eramo A, Comoglio PM, Giordano S. Migliore C, et al. Among authors: giordano s. Cancer Res. 2008 Dec 15;68(24):10128-36. doi: 10.1158/0008-5472.CAN-08-2148. Cancer Res. 2008. PMID: 19074879
1,027 results